The Wall Street Journal
Lilly’s Weight-Loss Drug Is a Huge Hit. Its CEO Wants to Replace It ASAP.
A deputy was calling with good news: The company’s new, experimental drug tirzepatide not only cut blood-sugar levels in people with diabetes in a small clinical trial, it also helped them lose ...
19 hours ago